Showing results (441-450 of 546) with videos related to

Sort By:
Pageof 55
Science Robotics|December 24, 2025
Efficacy and effectiveness of robot-assisted therapy for autism spectrum disorder: From lab to realityDaniel David, Paul Baxter, Tony Belpaeme, et al.
Plos One|August 22, 2020
The DREAM Dataset: Supporting a data-driven study of autism spectrum disorder and robot enhanced therapyErik Billing, Tony Belpaeme, Haibin Cai, et al.
Geburtshilfe Und Frauenheilkunde|March 7, 2020
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known TherapiesAndreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, et al.
ESMO Open|June 2, 2022
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer RegistryE Laakmann, I Witzel, T Neunhöffer, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
Cancers|October 1, 2020
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain MetastasesElena Laakmann, Isabell Witzel, Tanja Neunhöffer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyL Gianni, C S Huang, D Egle, et al.
Frontiers in Oncology|November 25, 2022
Deep-learning-based generation of synthetic 6-minute MRI from 2-minute MRI for use in head and neck cancer radiotherapyKareem A Wahid, Jiaofeng Xu, Dina El-Habashy, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer PatientsMichael P Lux, Andreas Schneeweiss, Andreas D Hartkopf, et al.
ESMO Open|November 28, 2025
Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX)T Link, M Reinisch, M Just, et al.
Pageof 55